XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.1
1. Basis of Presentation and Use of Estimates Organization, Consolidation and Presentation of Financial Statements (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales $ 700,062 $ 726,796    
Cost of goods sold 296,502 326,169    
Deferred Revenue 59,400   $ 71,000  
Retained earnings 10,137,628   13,507,241  
Accumulated other comprehensive loss (307,856)   (175,553)  
Total stockholders' equity $ 10,182,916 $ 10,609,059 13,667,134 $ 9,879,940
Revenue Allocation Percent To Lease Elements 2.00% 2.00%    
Additional paid-in-capital $ 459,431   441,733  
Selling, general and administrative expense 197,594 $ 225,853    
Research and Development Expense 62,543 73,912    
Interest expense 4,048 398    
Other Nonoperating Income (Expense) 32,597 17,407    
Deferred Revenue, Current 59,300   $ 50,900  
Europe [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 218,900 247,700    
Asia Pacific [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 160,900 168,900    
UNITED STATES        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 282,500 271,400    
Americas [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales $ 37,800 $ 38,800